These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6864446)

  • 1. [Attempt to analyze disposition of furosemide in rats using a compartment model].
    Asada S; Hamada M; Inui S; Nakae H
    Yakugaku Zasshi; 1983 Jan; 103(1):110-8. PubMed ID: 6864446
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-dependent pharmacokinetics of furosemide in the rat.
    Hammarlund MM; Paalzow LK
    Biopharm Drug Dispos; 1982; 3(4):345-59. PubMed ID: 7159689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
    Yang KH; Choi YH; Lee U; Lee JH; Lee MG
    J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics study of furosemide in healthy man (author's transl)].
    Gonzalez G; Arancibia A; Marinovic G; Moya JC; Antezana C; Ruiz I
    Therapie; 1980; 35(4):525-32. PubMed ID: 7466733
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of orally administered furosemide.
    Kelly MR; Cutler RE; Forrey AW; Kimpel BM
    Clin Pharmacol Ther; 1974 Feb; 15(2):178-86. PubMed ID: 4812154
    [No Abstract]   [Full Text] [Related]  

  • 6. The renal response to intravenous vanadate in rats.
    Day H; Middendorf D; Lukert B; Heinz A; Grantham J
    J Lab Clin Med; 1980 Sep; 96(3):382-95. PubMed ID: 6901758
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonrenal clearance of furosemide as a cause of diuretic response variability in the rat.
    Lambert C; Caillé G; du Souich P
    J Pharmacol Exp Ther; 1982 Jul; 222(1):232-6. PubMed ID: 7086701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of norendimide in rats.
    Koch HP; Pischek G; Czejka M; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1982; 4(8):581-5. PubMed ID: 7169846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simplified pharmacokinetic calculations in an open compartment model as exemplified by furosemide].
    Prandota J; Wilimowski M
    Pol Tyg Lek; 1976 Jan; 31(1):9-11. PubMed ID: 1250747
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.
    Wakelkamp M; Alván G; Gabrielsson J; Paintaud G
    Clin Pharmacol Ther; 1996 Jul; 60(1):75-88. PubMed ID: 8689815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of furosemide in functionally hepatectomized dogs.
    Verbeeck RK; Gerkens JF; Wilkinson GR; Branch RA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):479-83. PubMed ID: 7205627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of the loop diuretic furosemide on short latency auditory and vestibular-evoked potentials.
    Freeman S; Plotnik M; Elidan J; Sohmer H
    Am J Otol; 1999 Jan; 20(1):41-5. PubMed ID: 9918170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.
    Kedderis LB; Mills JJ; Andersen ME; Birnbaum LS
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):87-98. PubMed ID: 8337704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine on the absorption and efficacy of orally administered furosemide.
    Rogers HJ; Morrison P; House FR; Bradbrook ID
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):8-11. PubMed ID: 7056605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic interference between furosemide and cephalosporins].
    Iakovlev VP; Klimova VS; Em SV; Rudzit EA
    Antibiotiki; 1981 Apr; 26(4):287-90. PubMed ID: 7235669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced absorption of oral furosemide by bile juice in rats.
    Kim EJ; Han KS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1999; 104(1):107-10. PubMed ID: 10604283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
    Franson KL; Kuk JM; Lam NP; Lau AH
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetic model development and simulations for ethylene dichloride (1,2-dichloroethane) in rats.
    Sweeney LM; Saghir SA; Gargas ML
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):311-23. PubMed ID: 18579268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.